Monitoring investigators - Dr. Oestreich + Partner GmbH

We offer on-site and online monitoring of investigators in the context of clinical studies. Complex software solutions enable the efficient and reliable monitoring of investigator sites. Our experienced staff, who hold qualifications in a variety of fields, provide competent advice to the investigators during the conduction of the study. We also have an extensive pan-European network of local monitors and partners with ICH-GCP experience who enable the cost-effective monitoring of investigator sites during clinical studies.

Dr. Oestreich + Partner unites medical and technical expertise to provide the maximum quality while monitoring clinical trials. We provide our clients with the Internet-based software solutions OPVERDI and PMSBOX. OPVERDI is our proprietary electronic data capture (EDC) system with multilingual solutions developed specifically for the implementation of international clinical research projects. In addition to the electronic monitoring of the investigators, it enables numerous other procedures without requiring the presence of the monitor at the investigator site.

Click here for more information about monitoring investigators at Dr. Oestreich + Partner:

Monitoring investigators

Advantages of electronic monitoring for investigators

The monitoring of the clinical investigators enables all authorized parties to track clinical trials in real time via Internet-based systems. Project managers, internal staff and monitors stay in touch and can exchange information and coordinate procedures based on the latest results at any time. Regularly updated project folders also enable the monitors to prepare for their visits with the investigators. The use of state-of-the-art technology not only facilitates the protection of errors but also the simple correction of errors. Electronic channels accelerate communication and the exchange of information, saving considerable time. Moreover, all authorized participants have access to a central, consistent database that can be retrieved and analyzed extremely quickly. Changes in the study protocol and interim analyses can be flexibly adapted to other components during a study via electronic channels.

Click here for more information about our software solutions and monitoring investigators:

Monitoring investigators

EMA Pharmacovigilance
Health care studies
Observational studies
EMA Pharmacovigilance
Medical Biometrics
Approval of Medical Devices
Clinical Investigators
Clinical Trials
GCP Legislation
GCP - Good Clinical Practice
GCP Guidelines
GCP Compliance
Clinical Research Organisation
Contract Research Organisation
Pharmacoeconomics, Health
Pharmacoeconomic studies
Patient Monitoring
Monitoring Clinical Trials
Clinical Monitor
Marketing Authorisation
Medicinal Product Approval
Drug safety
Data management plan
Clinical development
Monitoring investigators
Non-interventional studies (NIS)
Patient recruitment
Phase IV studies
Investigator audit
Investigator qualification
Investigator selection

EMA Pharmacovigilance · Health care studies · Observational studies · EMA Pharmacovigilance · Medical Biometrics · Approval of Medical Devices · Pharmacovigilance · Clinical Investigators · Clinical Trials · GCP Legislation · GCP - Good Clinical Practice · ICH GCP E6 · GCP Guidelines · GCP Compliance · BfArM GCP · Clinical Research Organisation · Contract Research Organisation · PSUR · PSURs · Pharmacoeconomics, Health · Pharmacoeconomic studies · Pharmacoeconomics · Patient Monitoring · Monitoring Clinical Trials · Clinical Monitor · Marketing Authorisation · Medicinal Product Approval · Drug safety · Data management plan · Clinical development · Monitoring investigators · Non-interventional studies (NIS) · Patient recruitment · Phase IV studies · Investigator audit · Investigator qualification · Investigator selection